OS Therapies completed a warrant inducement and exchange offer with holders of outstanding warrants with an exercise price of $1.12 per share.
The offer raised $3.7 million in gross proceeds to accelerate commercial launch preparations for OST-HER2.
New warrants were issued at an exercise price of $3.00 per share with a forced exercise provision when the stock trades above $9.00.
Gross Proceeds
The warrant exchange raised $3.7 million in gross proceeds for OS Therapies.
New Warrants
New warrants were issued at an exercise price of $3.00 per share with a forced exercise provision above $9.00.
Future Funding
The company now has funding secured into 2027 for its operations.
- The completion of the warrant exchange positions OS Therapies to accelerate the commercial preparations for OST-HER2.
- Eliminating old warrants with an exercise price of $1.12 per share reduces potential short-selling activity in the company's stock.
The successful completion of the warrant exchange provides OS Therapies with the necessary capital to advance its strategic initiatives and potentially bring forward the commercialization of OST-HER2 in the United States.